1. Home
  2. INO vs NTIC Comparison

INO vs NTIC Comparison

Compare INO & NTIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Inovio Pharmaceuticals Inc.

INO

Inovio Pharmaceuticals Inc.

HOLD

Current Price

$0.73

Market Cap

100.4M

Sector

Health Care

ML Signal

HOLD

Logo Northern Technologies International Corporation

NTIC

Northern Technologies International Corporation

N/A

Current Price

$8.02

Market Cap

81.9M

Sector

Industrials

ML Signal

N/A

Company Overview

Basic Information
Metric
INO
NTIC
Founded
1979
1970
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Industrial Specialties
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
100.4M
81.9M
IPO Year
1999
1996

Fundamental Metrics

Financial Performance
Metric
INO
NTIC
Price
$0.73
$8.02
Analyst Decision
Buy
Analyst Count
4
0
Target Price
$6.75
N/A
AVG Volume (30 Days)
4.0M
7.8K
Earning Date
05-08-2026
04-09-2026
Dividend Yield
N/A
0.49%
EPS Growth
54.18
N/A
EPS
N/A
N/A
Revenue
$42,220,086.00
$84,234,474.00
Revenue This Year
$20,156.19
$12.49
Revenue Next Year
$421.95
$7.64
P/E Ratio
N/A
N/A
Revenue Growth
19.37
N/A
52 Week Low
$0.56
$7.16
52 Week High
$2.86
$10.03

Technical Indicators

Market Signals
Indicator
INO
NTIC
Relative Strength Index (RSI) 33.01 44.87
Support Level $0.56 $7.86
Resistance Level $1.24 $8.03
Average True Range (ATR) 0.07 0.17
MACD -0.02 0.02
Stochastic Oscillator 31.29 17.46

Price Performance

Historical Comparison
INO
NTIC

About INO Inovio Pharmaceuticals Inc.

Inovio Pharmaceuticals Inc is a clinical-stage biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from diseases associated with human papillomavirus (HPV), cancer and infectious diseases. INOVIO's platform harnesses the power of in vivo protein production, featuring optimized design and delivery of DNA medicines that teach the body to manufacture its own disease-fighting tools. Its candidate is INO-3107 for the treatment of recurrent respiratory papillomatosis (RRP), a chronic, rare and debilitating disease of the respiratory tract caused by HPV infection. In its completed Phase 1/2 clinical trial of INO-3107 for the treatment of HPV-6 and HPV-11-associated RRP.

About NTIC Northern Technologies International Corporation

Northern Technologies International Corp is a United States-based firm that develops and markets proprietary, environmentally beneficial products and services world wide either directly or through a network of joint ventures, distributors, and agents. It operates through two segments, which include ZERUST products and services and Nature-Tec products. Its main business is providing corrosion prevention solutions that are marketed under the ZERUST brand. The company also sells a portfolio of bio-based and biodegradable (compostable) polymer resin compounds and finished products marketed under the Nature-Tec brand. The ZERUST brand generates a vast majority of the revenue for the company. The company generates the majority of its revenue in the United States.

Share on Social Networks: